Market
First official statement on implications of Pfizer documents by March 2025?
2
Resolution / Starting Odds
FDA • 25%
Pfizer • 25%
CDC • 25%
WHO • 25%
Official press releases or public statements from the respective organizations
Story
U.S. Judge Orders FDA to Release More Pfizer COVID-19 Vaccine Trial Documents for Transparency
Dec 6, 2024, 09:24 PM
A U.S. District Judge Mark Pittman has ordered the FDA to release an additional million pages of documents from Pfizer's COVID-19 vaccine trials. This decision comes after the FDA's unsuccessful attempt to end a public records lawsuit, which sought transparency on the authorization of the vaccines. The court's order aims to provide greater public access to the data behind the vaccine's authorization, following previous efforts to expedite the release of such documents. The documents in question were initially sought to be hidden by the FDA, marking a significant win for transparency.
View original story
Similar markets
Independent Researchers • 25%
Pfizer • 25%
Government Agencies • 25%
Mainstream Media • 25%
Legal challenges against FDA • 25%
No significant impact • 25%
Policy changes in vaccine approval • 25%
Increased transparency and trust • 25%
Vaccine Safety • 25%
Effectiveness of Vaccines • 25%
FDA's Handling • 25%
Data Transparency • 25%
Increased trust in vaccines • 25%
Indifference • 25%
Increased demand for transparency • 25%
Decreased trust in vaccines • 25%
No • 50%
Yes • 50%
Investigation inconclusive • 25%
No significant contamination found • 25%
Contamination confirmed, no recall • 25%
Contamination confirmed, recall issued • 25%
Investigation initiated • 25%
No action taken • 25%
Warning issued • 25%
Recall issued • 25%
51-75% • 25%
26-50% • 25%
0-25% • 25%
76-100% • 25%
FDA • 25%
Pfizer • 25%
Public Health Organizations • 25%
No major impact on any organization • 25%